Literature DB >> 4925508

Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.

S R Hirsch, P F Viernes, R C Kory.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4925508      PMCID: PMC472218          DOI: 10.1136/thx.25.6.737

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  IATROGENIC BRONCHOSPASM OCCURRING DURING CLINICAL TRIALS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE.

Authors:  I L BERNSTEIN; R W AUSDENMOORE
Journal:  Dis Chest       Date:  1964-10

2.  Deoxyribonuclease in the treatment of purulent bronchitis.

Authors:  P C ELMES; J C WHITE
Journal:  Thorax       Date:  1953-12       Impact factor: 9.139

3.  Nebulization of N-acetylcysteine combined with a bronchodilator in patients with chronic bronchitis. A controlled study.

Authors:  R C Kory; S R Hirsch; J Giraldo
Journal:  Dis Chest       Date:  1968-12

4.  An evaluation of the effect of nebulized N-acetylcysteine on sputum consistency.

Authors:  S R Hirsch; R C Kory
Journal:  J Allergy       Date:  1967-05

5.  Sputum liquefying agents: a comparative in vitro evaluation.

Authors:  S R Hirsch; J E Zastrow; R C Kory
Journal:  J Lab Clin Med       Date:  1969-08

6.  Evaluation of changes in sputum consistency with a new instrument.

Authors:  S R Hirsch; R C Kory; L H Hamilton
Journal:  Am Rev Respir Dis       Date:  1966-11
  6 in total
  7 in total

1.  [Clinical-pharmacological studies on bronchosecretolysis].

Authors:  T C Medici; S Chodosh
Journal:  Pneumonologie       Date:  1975-09-26

Review 2.  Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines.

Authors:  Donald C Bolser
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

Review 3.  Appropriate use of antitussives and protussives. A practical review.

Authors:  R S Irwin; F J Curley; F M Bennett
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

4.  No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.

Authors:  M L Thomson; D Pavia; C J Jones; T A McQuiston
Journal:  Thorax       Date:  1975-12       Impact factor: 9.139

5.  Controlled trial of intermittent aerosol therapy with sodium 2-mercaptoethane sulphonate in cystic fibrosis.

Authors:  P H Weller; D Ingram; M A Preece; D J Matthew
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

6.  Effect of mucolytic and bronchodilator aerosol therapy on airway resistance in mechanically ventilated patients.

Authors:  D F Zandstra; C P Stoutenbeek; D R Miranda
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

7.  Evaluation of the Effect of Nebulized N-Acetylcysteine on Respiratory Secretions in Mechanically Ventilated Patients: Randomized Clinical Trial.

Authors:  Seyed Masoom Masoompour; Amir Anushiravani; Amir Tafaroj Norouz
Journal:  Iran J Med Sci       Date:  2015-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.